| Date Filed | Type | Description |
| 06/08/2023 |
4
| Knobil Katharine (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 06/08/2023 |
4
| Knobil Katharine (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 09/16/2022 |
4
| Knobil Katharine (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 30,000 options to buy
@ $24.23, valued at
$726.9k
|
|
| 09/16/2022 |
3
| Knobil Katharine (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2021 |
4
| Knobil Katharine (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 3,067 shares
@ $0
Granted 7,202 options to buy
@ $65.19, valued at
$469.5k
|
|
| 10/19/2020 |
4
| Knobil Katharine (Chief Medical Officer) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 67,500 options to buy
@ $8.69, valued at
$586.6k
|
|
| 06/16/2020 |
4
| Knobil Katharine (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 1,223 shares
@ $0
Granted 2,446 shares
@ $0
Granted 2,500 options to buy
@ $61.31, valued at
$153.3k
Granted 5,000 options to buy
@ $61.31, valued at
$306.6k
|
|
| 06/16/2020 |
3
| Knobil Katharine (Director) has filed a Form 3 on ARENA PHARMACEUTICALS INC |
| 04/17/2020 |
4
| Knobil Katharine (See Remarks) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 67,500 options to buy
@ $6, valued at
$405k
|
|
| 03/03/2020 |
4
| Knobil Katharine (See Remarks) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 15,843 restricted stock units
@ $0 |
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2019 |
3
| Knobil Katharine (See Remarks) has filed a Form 3 on Kaleido Biosciences, Inc. |